Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Carlsmed, Inc. - Common Stock (NQ:CARL)

9.740 -0.100 (-1.02%)
Streaming Delayed Price Updated: 3:30 PM EDT, May 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Carlsmed, Inc. - Common Stock

News headline image
Carlsmed (CARL) Q1 2026 Earnings Transcript ↗
Carlsmed (CARL) Q1 2026 Earnings Transcript 
Via The Motley Fool
Carlsmed (NASDAQ:CARL) Shares Surge on Q1 Earnings Beat and Raised Full-Year Guidance ↗
Via Chartmill
Topics Earnings
News headline image
Carlsmed® Reports First Quarter 2026 Financial Results
From Carlsmed
Via GlobeNewswire
News headline image
Carlsmed, Inc. To Participate in Upcoming Investor Conferences
From Carlsmed
Via GlobeNewswire
News headline image
Carlsmed Inc. to Report First Quarter 2026 Financial Results on May 5, 2026
From Carlsmed
Via GlobeNewswire
Carlsmed Inc (NASDAQ:CARL) Reports Q4 Revenue Beat and Narrower-Than-Expected Loss ↗
Via Chartmill
News headline image
Earnings Scheduled For November 6, 2025 ↗
 
Via Benzinga
News headline image
Carlsmed, Inc. To Participate in the 25th Annual Needham Virtual Conference
From Carlsmed
Via GlobeNewswire
News headline image
Carlsmed® Reports Fourth Quarter and Full Year 2025 Financial Results
From Carlsmed
Via GlobeNewswire
News headline image
Carlsmed, Inc. To Participate in the 2026 Canaccord Genuity Musculoskeletal Conference
From Carlsmed
Via GlobeNewswire
News headline image
Carlsmed Unveils Custom Cervical Plating Tech ↗
Carlsmed (NASDAQ: CARL) stock rises on news of first personalized cervical plating procedure with its corra system. 
Via Benzinga
News headline image
Carlsmed Announces first corra™ personalized Cervical Plating Procedure
The corra™ Cervical Plating System marks the debut of Carlsmed's patient-specific fixation portfolio 
From Carlsmed
Via GlobeNewswire
News headline image
Carlsmed Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026
From Carlsmed
Via GlobeNewswire
News headline image
Carlsmed Announces First aprevo® Bi-lateral Posterior Lumbar Interbody Fusion Procedure
From Carlsmed
Via GlobeNewswire
News headline image
Carlsmed Announces Preliminary Revenue for the Fourth Quarter and Full Year 2025
From Carlsmed
Via GlobeNewswire
News headline image
Carlsmed aprevo® Lumbar 2-year Data Published in Global Spine Journal
From Carlsmed
Via GlobeNewswire
News headline image
Carlsmed, Inc. To Participate in the J.P. Morgan 2026 Healthcare Conference
From Carlsmed
Via GlobeNewswire
News headline image
Carlsmed Announces U.S. Launch of its aprevo® Technology Platform for Cervical Fusion Surgeries at the Cervical Spine Research Society (CSRS) 53rd Annual Meeting
First 50+ cervical cases completed; observations on initial clinical experience to be presented by early adopters at the Carlsmed CSRS Lunch Workshop 
From Carlsmed
Via GlobeNewswire
News headline image
Carlsmed, Inc. To Participate in the Piper Sandler 37th Annual Healthcare Conference
From Carlsmed
Via GlobeNewswire
News headline image
Carlsmed Inc (NASDAQ:CARL) Reports Q3 2025 Revenue Beat and Raises Full-Year Guidance ↗
Carlsmed (CARL) reported strong Q3 2025 results, beating revenue and EPS estimates with 98% YoY growth. The AI spine surgery firm also raised its full-year revenue guidance. 
Via Chartmill
Topics Artificial Intelligence
News headline image
Carlsmed Reports Third Quarter 2025 Financial Results and Raises Full-Year Guidance
From Carlsmed
Via GlobeNewswire
News headline image
Carlsmed Inc. to Report Third Quarter 2025 Financial Results on November 6, 2025
From Carlsmed
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.